No information exists regarding COVID-19 in solid organ transplant recipients (SOTR)., Besides, treatment is challenging as drug interactions might have an important impact on drug toxicity, graft dysfunction and rejection and probably outcome is adverse. No specific recommendations regarding COVID-19 exist. Objectives: to better understand the incidence, risk factors, clinical manifestations and outcome of COVID19 in SOTR. The results obtained will allow us to gain insight on the need of antiviral treatment, on the strategy for complications surveillance, on how to adjust the immunosuppressant therapy and on the level of care in which each patient should be treated. Design: Multicenter prospective study of consecutive cases of COVID-19 in SOTR. There will be a clinical follow-up of the patients included in this study to observe possible complications and survival rate.
estudio prospectivo multicéntrico
receptores de trasplantes de órganos sólidos
interacciones medicamentosas
toxicidad
rechazo
supervivencia
incidencia
manifestaciones clínicas
COVID-19
SARS-CoV-2
Acción Estratégica en Salud (AES)
29/10/2021 - 30/01/2022
ELISA CORDERO MATIA
FUNDACION PUBLICA ANDALUZA PARA LA GESTION DE LA INVESTIGACION EN SALUD DE SEVILLA
FUNDACION PUBLICA ANDALUZA PARA LA GESTION DE LA INVESTIGACION EN SALUD DE SEVILLA
ANDALUCIA
SEVILLA
182,201 €